Skip to content
Home
About Us
Our Products
Therapies
Media
Careers
Contact Us
Home
About Us
Our Products
Therapies
Media
Careers
Contact Us
Media
Blogs
Media Coverage
October 13, 2025
Lorem Ipsum 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo 2....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 3
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 4
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 13, 2025
Lorem Ipsum 5
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
October 8, 2025
Lorem Ipsum
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo....
Read More
Lorem ipsum
Lorem ipsum
Emcure Pharma sets up subsidiary Emcutix Biopharmaceuticals focused on dermatology
The Hindu
October 28, 2025
Read More
Acne care gets a boost with Emcutix’s new Flawlizo range
Pharm India Magazine
June 8, 2025
Read More
Emcutix launches Flawlizo – targeted solutions for quick acne relief
Pharma Biz
June 6, 2025
Read More
Retail India News: Emcutix Biopharmaceuticals Forays into Acne Skincare with Flawlizo Xpert Acne Care
Indian Retailer
June 6, 2025
Read More
Emcutix Biopharmaceuticals Expands Skin Health Portfolio with SOLGLO Sunscreen Launch
Sahyadri Pulse
May 26, 2025
Read More
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
Join the
Emcutix Circle
Be the first to hear about new launches, skin insights, and insider stories.